会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 61. 发明公开
    • 간암 암 줄기세포 특성에 기초한 간암의 신규 바이오마커 및 그의 용도
    • 基于肝癌干细胞特征的肝癌新生物标志物及其用途
    • KR1020130010946A
    • 2013-01-30
    • KR1020110071749
    • 2011-07-20
    • 연세대학교 산학협력단
    • 송시영박수빈김선아
    • G01N33/574G01N33/68G01N33/15
    • G01N33/574G01N33/00G01N33/15G01N33/68
    • PURPOSE: A method for screening a material which prevents or treats liver cancer using a molecular marker for cancer stem cells and liver cancer is provided to accurately diagnosing liver cancer or cancer. CONSTITUTION: A kit for diagnosing liver cancer or analyzing liver cancer prognosis contains a binder which specifically binds to a protein of sequence number 1, 3, or 5 or a probe or a primer which specifically binds to a polynucleotide of sequence number 2, 4, or 6. A kit is a kit for immunoassay. A method for screening a material which prevents or treats liver cancer comprises a step of contacting a sample with a cell or a tissue containing the protein or polynucleotide; and a step of measuring expression level of the protein or polynucleotide.
    • 目的:提供一种筛选使用癌症干细胞和肝癌分子标志物预防或治疗肝癌的材料的方法,以准确诊断肝癌或癌症。 构成:用于诊断肝癌或分析肝癌预后的试剂盒含有特异性结合序列号1,3或5的蛋白质​​的结合剂,或特异性结合序列号2,4和5的多核苷酸的探针或引物, 或6.试剂盒是用于免疫测定的试剂盒。 用于筛选预防或治疗肝癌的材料的方法包括使样品与含有所述蛋白质或多核苷酸的细胞或组织接触的步骤; 以及测量蛋白质或多核苷酸的表达水平的步骤。
    • 62. 发明公开
    • 담도암 암 줄기세포 특성에 기초한 담도암 신규 바이오마커 및 그의 용도
    • 基于双侧牵引癌的胆管癌的新生物标志物干细胞特征及其用途
    • KR1020130010831A
    • 2013-01-29
    • KR1020120071292
    • 2012-06-29
    • 연세대학교 산학협력단
    • 송시영박수빈김선아박정엽
    • C07K16/18G01N33/15G01N33/68G01N33/574
    • PURPOSE: A method for screening a material which prevents or treats biliary tract cancer using a novel molecular marker is provided to screen a therapeutic agent candidate which is specific to biliary tract cancer stem cells or cancer stem cells. CONSTITUTION: A method for screening a material which prevents or treats biliary cancer comprises: a step of contacting a sample with a cell or a tissue containing a protein of sequence number 1 or 3 or a polynucleotide of sequence number 2 or 4; and a step of measuring expression level of the protein or polynucleotide. The protein exists on the cell surface, viral surface, or in an isolated form. A kit for detecting biliary cancer stem cells contains a primer or a probe which specifically binds to the protein or polynucleotide. [Reference numerals] (AA) Expressing TAGLN2 at normal biliary epithalial tissue and biliary cancer tissue
    • 目的:提供一种用于筛选使用新型分子标记物预防或治疗胆道癌的材料的方法,以筛选对胆道癌干细胞或癌干细胞特异性的治疗剂候选物。 构成:用于筛选预防或治疗胆汁癌的材料的方法包括:将样品与含有序列号1或3的蛋白质的细胞或组织或序列号2或4的多核苷酸接触的步骤; 以及测量蛋白质或多核苷酸的表达水平的步骤。 蛋白质存在于细胞表面,病毒表面或分离形式。 用于检测胆道癌干细胞的试剂盒含有特异性结合蛋白质或多核苷酸的引物或探针。 (AA)在正常胆道骨髓组织和胆道癌组织中表达TAGLN2